We have analysed the radiation response of a human medullary thyroid carcinoma cell line (MTT), characterized by the absence of a functional p53 protein, and the consequences of MDM2 overexpression in this process. We show that the product of the mdm2 proto-oncogene is able to sensitize MTT cells to ionizing radiation. After radiation treatment, MTT cells display histograms consistent with a G2M arrest. MTT cells expressing MDM2 (MTT-mdm2) are unable to respond to DNA damage with G2M arrest, and display a high percentage of apoptosis. MTT-mdm2 cells show high levels of E2F-1 protein, suggesting that the induction of apoptosis observed upon MDM2 overexpression could be dependent on E2F-1. This observation is further supported with assays showing that E2F-1 binding to speci®c DNA sequences is enhanced in MTT-mdm2 cells. Likewise, transactivation of reporter constructs exclusively dependent on E2F-1 is also elevated after transfection with MDM2. This eect can be reverted by transient transfection with p19 ARF . To link the expression of E2F-1 with the induction of apoptosis, we generated clonal cell lines overexpressing E2F-1. Transfection with E2F-1 results in a low number of outgrowing colonies with reduced proliferation rates, indicating that E2F-1 is deleterious for cell growth. This negative regulation correlates with an increase in the percentage of the cell population with DNA content below 2N, suggesting that E2F-1 promotes apoptosis. Finally, overexpression of E2F-1 sensitizes MTT cells to radiation exposure. We conclude that the eects observed by MDM2 overexpression could be mediated by E2F-1.
Introduction
Cellular response to ionizing radiation is a complex mechanism involving multiple pathways. Over the last years, extensive research has determined how dierent oncogenes and tumor suppressor genes modify the intrinsic sensitivity of neoplastic cells to radiation treatment. A positive correlation between the expression of oncogenes and the radiation response of various malignant cell lines has been established, and it is now widely accepted that some oncogenes such as ras, raf, myc or trk play a role in modulating the sensitivity to ionizing radiation (Sawey et al., 1987; Kasid et al., 1989; Chang et al., 1987; Pirollo et al., 1993) . The establishment of this association may have clinical implications in supporting rational use of radiotherapy for dierent tumor types.
Medullary carcinoma of the thyroid (MTC) is an uncommon malignancy derived from the C cells of the thyroid gland and accounts for up to 10% of all thyroid neoplasias. Most of the cases of MTC are sporadic, although a signi®cant percentage (around 20%) are genetically determined and are associated with inherited syndromes known as Multiple Endocrine Neoplasia (MEN) 2A, MEN 2B and Familial Medullary Thyroid Carcinoma (FMTC) (Giurida and Gharib, 1998; Nelkin et al., 1989, Vecchio and Santoro, 2000) . Clinical management of thyroid carcinoma relies mainly on surgery, although external radiation treatment, alone or in combination with chemotherapeutic agents, is also applied in some cases of metastatic MTC (Heshmati et al., 1997) . The analysis of the genetic markers related to thyroid carcinogenesis could help to improve the management of this disease (Puxeddu and Fagin, 2001 ) Several human and rat MTC cell lines have been established and analysed both genetically and phenotypically (Carlomagno et al., 1995; Velasco et al., 1997) . Among them, the MTT cell line displays most of the MTC markers including expression of calcitonin, somatostatin and somatostatin receptors (Medina et al., 1999) . These cells, highly tumorigenic when injected into nude mice, carry a major rearrangement of the TP53 locus (Velasco et al., 1997) .
MTT cells are also devoid of MDM2 (Dilla et al., 2000) , the product of the murine double-minute oncogene, initially identi®ed in spontaneously transformed murine ®broblasts (Cachilly-Snyder et al., 1987) . The mdm2 oncogene possesses transforming activity and it is activated by overexpression, ampli®cation or enhanced translation in dierent types of human tumors, mainly in sarcomas (Oliner et al., 1992) . At low incidence, ampli®cation of MDM2 has also been detected in gliomas, breast cancer and non-small cell lung carcinomas (Momand and Zambetti, 1997; Zhang and Wang, 2000) . MDM2 plays a pivotal role in cell proliferation through functional interactions with the tumor suppressor gene product p53 (Momand et al., 1992) . This interaction results in the inactivation of p53 function by a mechanism involving protein degradation (Haupt et al., 1997; Kubbutat et al., 1997) . Besides, MDM2 also interacts with other proteins, such as retinoblastoma, E2F-1, the TATA box binding protein and the ribosomal protein L5 (Lozano and Montes de Oca Luna, 1998) .
Overexpression of MDM2 is generally linked with an advantage in cell proliferation and predisposition to tumorigenesis. In vitro, MDM2 is able to transform dierent cell lines in combination with other oncogenes (Finlay, 1993) . Likewise, transgenes encoding the MDM2 protein promote tumorigenesis in dierent tissue environments (Ganguli et al., 2000) . However, some unexpected properties of MDM2 have been also described. When overexpressed in NIH3T3 cells, MDM2 is able to arrest the cell cycle (Brown et al., 1998) . In human medullary carcinoma cells, our laboratory has recently shown that MDM2 promotes apoptosis through a mechanism involving a downregulation of Bcl2 (Dilla et al., 2000) . Results from tissue speci®c transgenic mice have also shown that MDM2 not always predispose to tumorigenesis (Alkhalaf et al., 1999) , supporting the notion that the biological response to MDM2 overexpression is cell type speci®c.
The participation of MDM2 in response to DNA damage has been investigated. Particularly, MDM2 protein levels are elevated upon ionizing radiation exposure (Chen et al., 1994) . This response seems to require the presence of a functional p53 protein, and occurs in parallel with other p53 downstream eectors such as p21
Cip1/WAF1 and Bax (El-Deiry et al., 1993; Zhan et al., 1994) . The biological consequences of this MDM2 upregulation remain unclear. In the presence of p53, MDM2 could be responsible for targeting p53 for degradation. However, MDM2 may have additional functions in the absence of p53, situation commonly found in human tumors. In this paper we have analyzed the response of the human medullary thyroid carcinoma cell line MTT to ionizing radiation, and the eect of MDM2 overexpression in this process. The results show that MDM2 induces a signi®cant sensitization of MTT cells to ionizing radiation. Further assays allow us to implicate the E2F-1 transcription factor in this sensitization process.
Results

MDM2 sensitizes human medullary thyroid carcinoma cells (MTT) to ionizing radiation
The eect of MDM2 on cell proliferation of the human medullary thyroid carcinoma cell line MTT has been previously investigated. The isolation of clones that constitutively expressed MDM2 allowed us to demonstrate that this oncoprotein exerts a negative eect on cell growth by promoting apoptosis (Dilla et al., 2000) . Here in this study we have analysed the response of these human MTC cells to ionizing radiation, and the eect of MDM2 in this response. For that purpose, mock-transfected (pC-MTT) and two independent clones of MDM2-transfected MTT cells (MTTmdm2-c1 and -c4) were seeded at low density and subjected to increasing doses of g-radiation (0 ± 10 Gy). Then, surviving cells were allowed to grow as individual clones. Visual examination of the cells under the microscope revealed that after low doses of radiation (4 2 Gy), MTT cells still maintained a typical ®broblast-like morphology (Velasco et al., 1997) , whereas colonies from MTT-mdm2 cells showed signs of cellular fusion, condensation of nuclei and eventual nuclear disintegration (data not shown). To quantify the eects of the radiation treatment, colonies were stained and scored by clonogenic assays. Data were analysed and the survival curves corresponding to the linear quadratic model represented (Figure 1a ). The survival fraction at 2 Gy (SF2) was signi®cantly lower in MDM2 expressing cells compared with the parental cells (0.88 for MTT, 0.59 and 0.61 for MTT-mdm2 clones c1 and c4, respectively), indicating that MDM2 sensitizes MTT cells to g-radiation.
To assure that constitutively transfected cells express MDM2, nuclear extracts from control transfections with empty vector and the two clones described above were isolated, resolved by electrophoresis and immunoblotted with an speci®c human MDM2 monoclonal antibody. A unique polipeptide was detected at the expected molecular mass was observed in the two transfectants (Figure 1b) .
Cell cycle distribution in MTT and MTT-mdm2 cells after radiation
To further analyse the radiation eect on cell proliferation, we determined cell cycle distribution of the parental (MTT) and transfected cells (MTT-mdm2 clone c1 and c4) after radiation exposure (Table 1) . Cultures were treated with 5 Gy radiation dose and DNA content was then analysed by¯ow cytometry ( Figure 2 ). As previously described, cell cycle distribution of the parental cell line showed histograms corresponding with actively dividing cells (59.21% G0 ± G1, 17.29% S, 21.46% G2-M). Only 2% of the cell population presented DNA content below 2N. Radiation treatment of MTT cells resulted in a G2-M arrest of the cell population. After 24 h, we observed a signi®cant reduction in the G1 fraction (59.21 to 39.27%), concomitant with an increase in the G2-M phase (21.46 to 33.16%). This G2-M accumulation increased reaching the maximum percentage 48 h after treatment (52.04%). Cell cycle distribution of MTTmdm2 cells after radiation was also analysed. Nonirradiated controls in both clones showed a 35% cell fraction below diploid status, in keeping with previously described data showing MDM2-mediated induction of apoptosis (Dilla et al., 2000) . Twenty-four hours after treatment, we found no signi®cant changes in the histograms. Unlike MTT cells, MDM2 expressing clones failed to accumulate in G2-M, and continued showing a high proportion of hypodiploid cells. After 48 h, this percentage of apoptotic cells increased signi®cantly, reaching almost half of the cell population (46.18 and 39.95% for c1 and c4, respectively). To demonstrate that the eect is a direct consequence of the radiation treatment and not due to the evolution of MTT-mdm2 cells in culture, we analysed cell cycle distribution of non-irradiated cells after 24 and 48 h in culture. Hypodiploid values ranged again around 35% and cell cycle distribution was undistinguishable to that obtained at the beginning of the experiment (data not shown).
To unambiguously demonstrate that hypodiploid cells detected by¯ow cytometry correspond to cells undergoing apoptosis, MTT and MTT-mdm2-c1 cells were collected and labeled with annexin V (Table 2) . We found only background levels of¯uorescence in control and irradiated MTT cells (around 1%), con®rming that radiation does not induce apoptosis in the parental cells. Consistent with cell cycle histograms, we observed a signi®cant percentage of non-irradiated MTT-mdm2 cells positive for annexin labeling. This population of annexin positive cells slightly increased 24 h after radiation, reaching maximum value at 48 h, when dierences with nonirradiated controls were signi®cant (31.3 vs 18.2). From these results, we conclude that radiation enhances apoptotic eects mediated by MDM2 in MTT cells.
MDM2 up-regulates E2F-1 protein levels
We investigated molecular mechanisms that could explain the phenotypic characteristics of MTT-mdm2 cells, including growth retardation, induction of apoptosis and sensitization to g-radiation. We searched for changes in regulatory proteins that upon either induction or repression mediated by MDM2 could be responsible for the promotion of apoptosis in MTT cells. Since these cells are naturally devoid of p53, we narrowed down the analysis to proteins that could induce apoptosis through p53-independent pathways.
The product of the E2F-1 gene, initially identi®ed as a growth promoting transcription factor, has been recently described as an apoptosis inducer in dierent tumor cell lines (Phillips et al., 1999; Hunt et al., 1997; Liu et al., 1999; Dong et al., 1999) . Moreover, E2F-1 induction of apoptosis does not require a functional p53, at least in human breast and ovarian carcinoma cells (Hunt et al., 1997) . We tested whether in MTT cells, the eect observed upon MDM2 overexpression could be mediated by E2F-1. Figure 3 shows Western analysis using polyclonal antibodies for the E2F-1 protein in MTT and MTT-mdm2 cell extracts (clone c1 and c4). Results demonstrate that MDM2 upregulates cellular levels of E2F-1. Quanti®cation of the signal from three independent experiments revealed that basal levels of the E2F-1 transcription factor are increased more that threefold in both clones overexpressing MDM2.
To support any functional implication to the upregulation of E2F-1 detected by immunoblotting, we tested the ability of E2F-1 to bind a speci®c DNA sequence in gel shift assays. As shown in Figure 4a , basal levels of E2F-1 binding were observed when MTT cell extracts were incubated with an oligonucleotide containing a consensus E2F-1 recognition site. This signal corresponds to the endogenous levels of E2F-1 present in MTT cells. The protein-DNA complex was clearly augmented in two independent clones (c1 and c4) transfected with MDM2, indicating that the elevation of E2F-1 protein levels detected by Western blot in MTT-mdm2 cells correlates with a greater capacity of E2F-1 to bind DNA. In fact, the intensity of the signal was similar to that obtained when an expression vector for E2F-1 was transfected in MTT cells. The speci®city of the DNA/protein complex was con®rmed by competition assays. Extracts from MTT cells were incubated with an excess of unlabeled E2F-1 binding oligonucleotide, or an unrelated sequence prior to the addition of the labeled probe. Unlabeled E2F-1 binding oligonucleotide, but not the unrelated one, competed with the radiactive probe.
E2F-1 binding to speci®c DNA sequences promotes transcription of E2F-1-regulated target genes. To ascertain whether the increased DNA-protein complex results in any eect in gene transcription, we carried out transient transfection assays using expression vector for MDM2, in combination with reporter constructs in which expression of luciferase is driven by three tandem sequences of E2F-1 consensus binding sites (p36E2F-Luc). A reporter constructs carrying mutated E2F-1 sequences were used as negative control (p36E2Fmut-Luc). Results are represented in Figure  4b . When p36E2F-Luc was transfected alone, transactivation from the endogenous E2F-1 was detected in MTT cell extracts, whereas p36E2Fmut-Luc yielded very low values of luciferase. Transactivation of p36E2F-Luc was clearly increased in MTT cells when cotransfected with pC-mdm2, con®rming the capacity of MDM2 to promote E2F-1 dependent transcription. As expected, no activity was observed when p36E2F-mut-Luc was used instead of p36E2F-Luc.
E2F-1 protein levels and transactivation after exposure of MTT and MTT-mdm2 cells to ionizing radiation
We then analysed the eects of radiation exposure on E2F-1 protein levels and transactivation in MTT and MTT-mdm2 cells. Cultures were subjected to radiation treatment (5 Gy) and extracts were collected for Western blot after 48 h. Basal levels of E2F-1 in MTT cells were not modi®ed by radiation treatment ( Figure 5a ). As previously observed, E2F-1 protein levels in MTT-mdm2 were clearly elevated respect to control cells. Similar levels of E2F-1 protein were found in MTT-mdm2 cells exposed to radiation treatment.
To determine whether exposure to radiation aects E2F-1-dependent gene transcription, transactivation assays were performed in MTT and MTT-mdm2 cells. Twenty-four hours after transfection with p36E2F-Luc, cells were subjected to a 5 Gy dose of radiation, and 48 h later extracts were assayed for luciferase activity to measure E2F-1 dependent transactivation. Data was normalized for transfection eciency by measuring CAT activity driven by pRSV-CAT ( Figure  5b ). Compared with basal transcription detected in MTT cells, radiation slightly increased E2F-1 activity, although this eect was not signi®cant. Consistent with previous observations (Figure 4 ), E2F-1 activity was augmented in MTT-mdm2 cells. Radiation exposure further increased E2F-1 dependent transactivation. Results demonstrated that radiation enhances the ability of MDM2 to up-regulate E2F-1 dependent activity, not by increasing protein levels, but by modulating E2F-1 transactivation capacity.
p19
ARF reverts the ability of MDM2 to transactivate E2F-1
We have previously shown that MDM2 induction of apoptosis can be partially reverted by transient transfection with p19 ARF (Dilla et al., 2000) . Therefore, if E2F-1 transactivation was dependent on MDM2, it should be reverted by p19
ARF when co-expressed with MDM2. Also, p19
ARF should be capable to decrease the constitutively activated E2F-1 transcription in MTT-mdm2 cells. To test this hypothesis, MTT cells were transfected with p36E2F-Luc and pC-mdm2 in the absence or presence of p19 ARF . To assure that both MDM2 and p19 ARF proteins are eciently expressed in the transient transfection experiments, we checked protein levels in Western analysis using extracts from MTT and MTT cells transfected with either pC-mdm2 or pC-p19 ARF . As shown in Figure 6b , p19 ARF and MDM2 protein levels were clearly elevated upon transfection with the corresponding plasmids.
Results from the transfection experiments showed that pC-mdm2 increased activity from p36E2F-Luc by threefold. This activation was blocked by p19 ARF , which reverted luciferase values to almost basal levels. In the absence of MDM2, p19 ARF had little eect on E2F-1 transcription (Figure 6a, left) . In MTT-mdm2, we measured the ability of p19 ARF to modulate constitutive activity of E2F-1. As shown in Figure 6a (right), p19
ARF inhibited E2F-1-dependent transactivation. From these results, we conclude that E2F-1 transcriptional activity is regulated by MDM2 through a p19 ARF controlled mechanism.
E2F-1 exerts a negative effect on MTT cell growth by promoting apoptosis
The results presented above demonstrated that E2F-1 protein levels are upregulated in MTT cells transfected with MDM2. As mentioned, several reports indicated that E2F-1 inhibits cell growth by promoting apoptosis in particular tumor cell lines (Oswald et al., 1994; Phillips et al., 1999; Hunt et al., 1997; Liu et al., 1999) . From both observations we reasoned that in MTT cells, elevation of E2F-1 protein levels could be responsible for the phenotypic characteristics observed in MTT-mdm2 cells, including growth retardation, apoptosis and sensitization to radiation. If this is the case, we should be able to mimic MDM2 eect in MTT cells by directly upregulating E2F-1. To test this hypothesis, a mammalian expression vector carrying the full-length human E2F-1 cDNA was transfected into MTT cells. Selection (G-418) was maintained for 4 weeks. After that period, the eect of E2F-1 on MTT Figure 3 E2F-1 transcription factor is upregulated in MTT cells overexpressing MDM2. Protein extracts from the parental (MTT) and MDM2 transfected cells (clones c1 and c4) were resolved by SDS ± PAGE electrophoresis, probed with an E2F-1 polyclonal antibody and revealed by chemiluminiscence. After exposure, the membrane was stripped and probed with an actin antibody to assess equal loading of the samples. Quanti®cation of three independent experiments is shown in the lower panel, where an arbitrary value of one was assigned to the average intensity of E2F-1 in MTT cells. SD is also shown for each bar growth was determined by the ability of the transfected cells to grow and form single colonies. Representative assays are shown in Figure 7a . Cells were stained with crystal violet to determine colony formation in the presence or absence of E2F-1. Compared with the control transfections, expression of E2F-1 signi®cantly decreased colony formation. Colony outgrowth inhibition was comparable to that found after transfection with MDM2. The results indicate that E2F-1 exerts a negative eect on MTT cell growth. To quantify growth retardation induced by E2F-1, we generated stable cell lines overexpressing E2F-1. As shown in Figure 7b , this cells constituvely overexpressed E2F-1. We then expanded and seeded pC-MTT and MTT-E2F-1 to determine the proliferation rate of both cell lines for 4 consecutive days. After 2 days in culture, the ability of E2F-1 to inhibit cell growth was already evident, reaching 50% cell growth inhibition after 4 days (Figure 7c ). We then tested whether, as hypothesized, E2F-1 could be promoting apoptosis of MTT cells. We determined sub G0 ± G1 population in cell cycle histograms from asynchronous MTT and MTT-E2F-1 cells by¯ow cytometry. As shown in Figure  7d , overexpression of E2F-1 signi®cantly elevated the proportion of subG0 ± G1 nuclei to values similar to those previously found after MDM2 overexpression. From all these results, we conclude that E2F-1 transcriptional activity is responsible for MDM2 induction of apoptosis.
E2F-1 sensitizes MTT cells to ionizing radiation
Finally, we analysed whether overexpression of E2F-1 was able to modify the intrinsic radiation response of MTT cells. Cells were seeded at low density and subjected to increasing doses of g-radiation. Outgrowing colonies were counted to determine the eect on cell survival. Results from the linear quadratic ®ts are represented in Figure 8 . Analysis of the data revealed signi®cant dierences in the radiation survival curves. SF2 values determined for MTT-E2F-1 cells were lower than those found in the controls (0.58 vs 0.88).
Discussion
Intrinsic cellular response to ionizing radiation can be modi®ed by ectopic oncogene expression, suggesting that oncogenes play a role in the radiation response of mammalian cells both in vivo and in vitro. Here we report that the product of the mdm2 oncogene is able to increase the radiation sensitivity of human tumor cells derived form medullary thyroid carcinoma.
After radiation treatment, MTT cells are accumulated in the G2M phase of the cell cycle. This response to DNA damage is commonly found in many tumor cell lines regardless of the status of the p53 protein (Hwang and Muschel, 1998 (2610 6 ) were transfected with either a wild-type or mutated E2F-1 reporter constructs (p36E2F-Luc and p36E2Fmut-Luc), alone or in combination with an expression plasmid for MDM2 (pC-mdm2). In all cases, transfection eciency was corrected with the activity of chloranfenicol acetyltransferase, driven by the pRSV ± CAT construct. Values are represented as Luc/CAT activity, in arbitrary units. The mean+s.d. of three independent experiments are shown radiation with a G1 arrest, which allow the repair machinery to act before DNA is duplicated in the S phase (Hwang and Muschel, 1998; Illiakis, 1997) . In fact, we have observed that when p53 is introduced in these MTT cells, response to DNA damage is partially restored, cells accumulated in G1 after radiation and survival is increased (Velasco and Santisteban, unpublished observations) . On the other hand, here we show that the introduction of MDM2 causes MTT cells to fail G2M arrest and instead, induces cell death by apoptosis. Results also show that MDM2 overexpression leads to sensitization of MTT cells to radiationinduced apoptosis. This observation might explain clonogenic inhibition detected in the survival curves after radiation exposure.
We have explored molecular mechanisms that could link the expression of MDM2 with the induction of apoptosis in MTT cells. In previous reports, we have demonstrated that this process is associated with a down-regulation of the antiapoptotic protein bcl-2 and involves the upregulation of caspase 2 (Dilla et al., 2000) . Experiments described in Figures 3 and 4 allow us to conclude that MDM2 overexpression leads to an increase in E2F-1 protein levels, which in turn results in a greater capacity to bind speci®c DNA sequences in gel shift assays. Moreover, results obtained from transient transfections ruled out the possibility that overexpression of E2F-1 in MTT-mdm2 cells was just a casual phenomenon that occurred during the selection process of the cells. As shown in Figure 4b , E2F-1-dependent transactivation is detected in MTT extracts 72 h after transfection with MDM2. From all these results, we hypothesized that the eect induced by MDM2 could be in part mediated by E2F-1. Elevation of E2F-1 upon MDM2 overexpression could be either due to a transcriptional mechanism or stabilization of the protein. Recently, the latter mechanism has been described in pathways leading to apoptosis upon DNA damage. Moreover, speci®c phosphorylation sites within the E2F-1 sequences have been identi®ed as responsible for accumulation of the E2F-1 protein (Lin et al., 2001) . Whether this particular mechanism for E2F-1 accumulation occurs in MTT cells upon MDM2 overexpression remains to be investigated.
It is described that this transcription factor is crucial for a precise cell regulation of the cell cycle (Ohtani, 1999) . Other studies have attributed oncogenic properties to E2F-1, although more recent reports have also demonstrated that E2F-1 is able to promote apoptosis when overexpressed (Phillips et al., 1999) . For instance, adenoviral transfer of E2F-1 produced generalized apoptosis in dierent tumor types, including breast, ovarian, head and neck carcinoma and melanoma cells (Hunt et al., 1997; Liu et al., 1999; Dong et al., 1999) . Therefore, whereas the normal function of E2F-1 in cell cycle progression controlling transition to S phase is well described, the consequences of its overexpression may lead to dierent responses, favoring transformation or apoptosis depending on the cell type (Johnson, 2000) .
The interplay between MDM2 and E2F-1 has been analysed recently in several reports. Initially, it was shown that MDM2 promotes E2F-1 transactivation though a mechanism involving a physical contact of both proteins (Martin et al., 1995) . The observation was made in SAOS cells, characterized by the absence of a functional p53, suggesting that the eect is independent of p53. Our results are in the context of this observation since (i) MDM2 leads to an increment in E2F-1 transactivation and (ii) MTT cells are also devoid of p53. Other reports, although con®rm the physical interaction between the two proteins in the same cell line, propose a dierent biological outcome describing a reduction of E2F-1 dependent activity mediated by MDM2 (Loughran and La Thange, 2000) .
Radiation exposure neither changes E2F-1 protein levels nor transactivation activity in MTT cells. This results is in keeping with the knowledge that upregulation Figure 5 E2F-1 protein levels and activity in MTT and MTTmdm2 cells exposed to radiation. (a) protein samples from either non-irradiated cells (0) or cultures exposed to 5 Gy of radiation (5) were collected after 48 h and separated by SDS ± PAGE. Immunoblotting was performed using E2F-1 antibodies. (b) E2F-1-dependent transactivation in MTT and MTT-mdm2 cells after radiation. MTT and MTT-mdm2 cells were transfected with the reporter vector p36E2F-Luc. After 24 h, plates were either nontreated or exposed to a 5 Gy dose of radiation and 48 h later, E2F-1 dependent transactivation was measured as the levels of luciferase activity. The results were corrected for transfection eciency using a RSV ± CAT expression plasmid. Results were performed by triplicate and are represented as the mean+s.d.
of E2F-1 in response to DNA damage requires the presence of a functional p53 (Blattner et al., 1999) . However, it is of special interest the observation that in MTT-mdm2 cells, although E2F-1 levels are not modi®ed by radiation, transactivation from a E2F-1 speci®c construct was signi®cantly elevated. This fact may contribute to the increased amount of apoptotic cells detected after radiation exposure.
Previous observations from our laboratory indicated that MDM2 induction of apoptosis is partially reverted by p19 ARF (Dilla et al., 2000) . The product from this tumor suppressor gene has been shown inhibit MDM2 function (Zhang et al., 1998) . We then tested whether E2F-1 activity could be blocked by transient expression of p19 ARF . We show that in MTT-mdm2 cells, p19 ARF overexpression reverts E2F-1 dependent transactivation to values similar to those obtained in the parental cell line. These results are also reproduced in the parental MTT cell line by co-transfection of MDM2 and p19 ARF . The results indicate that E2F-1 transactivation activity is directly dependent on MDM2 and mediates MDM2-induction of apoptosis in MTT cells.
Our data also support the notion that overexpression of E2F-1 induces sensitization of MTT cells to radiation. Either through MDM2 overexpression, or when directly transfected in MTT cells, resulting clones exhibit greater sensitivity to radiation than parental or empty vectortransfected cells. This link between E2F-1 overexpression and radiation sensitization is in keeping with previous reports describing sensitizing properties of E2F-1 to dierent DNA damage (Banerjee et al., 1998) . For instance, intrinsic overexpression of E2F-1 is found in Ataxia telangectasia cells (Varghese and Jung, 1998) , which are hypersensitive to radiation. Also, ectopic expression of E2F-1 in ®brosarcoma cells results in increased cytotoxicity induced by radiation (Pruschy et al., 1999) . As we observe in our study, E2F-1 sensitization to radiation is independent of p53, since both reports have in common the use of cell lines devoid of wild-type p53. It is not de®ned yet whether lack of p53 is a requirement for E2F-1 dependent apoptosis.
In summary, our results indicate that MDM2, presumably through elevation of E2F-1 protein levels, is responsible for a radiosensitization of MTT cells to ionizing radiation. Screening of tumor samples and cell lines in which MDM2 is overexpressed, either by increased translation or gene ampli®cation, will contribute to determine whether radiosensitizing properties of MDM2 are restricted to particular tumor types.
Materials and methods
Cell culture
Medullary thyroid carcinoma cells MTT were derived from the human TT cell line (Leong et al., 1981) . They carry a severe rearrangement of the TP53 locus that leads to the absence of either p53-speci®c transcripts or protein. These cells were routinely maintained in RPMI1640 medium supplemented with 10% FBS, 2 mM glutamine, 100 mg/ml sodium piruvate, 100 U/ml penicillin and 100 mg/ml streptomycin. MTT cells overexpressing MDM2 and E2F-1 were maintained in the same medium with a 200 mg/ml concentration of geneticin (G-418).
Plasmids and transfections
Generation of MTT cells lines overexpressing MDM2 has been described previously (Dilla et al., 2000) . A mammalian expression vector for E2F-1 (pC-E2F-1) was generated by Cell extracts from control transfections and either pC-p19ARF or pC-MDM2 cells were subjected to SDS ± PAGE and blotted with speci®c antibodies for p19 or MDM2. Blots were then stripped and probed with and actin antibody for loading control cloning of the human full-length E2F-1 cDNA (Helin et al., 1992) into the BamHI site of the pCDNA expression vector. Transfection of both pCDNA and pC-E2F-1 (2 mg each) were performed using Lipofectin reagent (Life Technologies, Gaithersburg MD, USA). An expression vector for MDM2 was also used as control. Transfected cells were selected for three weeks with G418 (400 mg/ml). At that point, representative plates were stained with crystal violet to determine the number of outgrowing colonies from each experimental group. Other plates were used to generate established cell lines overexpressing E2F-1. For that purpose, isolated colonies were trypsinized individually and expanded. For transactivation assays, transient transfections with wild-type or mutated E2F-1 reporter constructs (Lam and Watson, 1993) , with or without expression vectors for MDM2 were also carried out in MTT cell cultures. Seventy-two hours after transfection, cells extracts were prepared and chloramphenicol acetyltransferase (CAT) and luciferase (Luc) were determined as previously described (Velasco et al., 1998) . For these assays, an expression vector for p19 ARF was also used (Kelle et al., 1995) Radiation survival curves Cells in exponentially growing cultures were collected by trypsinization, washed twice in PBS and plated at dierent densities in 25 cm 2 tissue culture¯asks. Radiation treatments were performed with an AECL Theratron 80 Clinical 60 Co irradiator at a dose of 2 Gy/min. After treatment, colonies were allowed to grow for 12 days, ®xed in 70% methanol and then stained with 0.5% crystal violet in 70% methanol. Colonies containing at least 50 cells were counted to determine cell survival. The surviving fraction was calculated as the ratio of the plating eciency or irradiated cells to that of control cells. Data from triplicate experiments were grouped for each dose and ®tted to the linear-quadratic model, using the least square method (Albright, 1987) . There was a good ®tting of the experimental values with a correlation coecient (r 2 ) over 0.9 in all cases. The survival fraction at 2 Gy (SF2) was calculated to compare radiation sensitivity.
Growth, cell cycle distribution and detection of apotosis
Growth curves were performed in 6 cm plates, seeding 5610 4 cells/plate. Cell number was determined in triplicate experiments every 24 h for 4 consecutive days. Trypan blue staining was used to exclude non-viable cells. Cell cycle distribution was determined from asynchronous cultures by FACS analysis. Cells were trypsinized, washed in PBS and ®xed in 70% ethanol. After centrifugation, cells were resuspended in a solution containing 10 mg/ml propidium iodide and 5 mg/ml RNase and analysed in a¯ow cytometer (Becton Dickinson, San Jose CA, USA). At least 10 000 events were collected for Apoptosis was monitored by Fluorescein (FITC)-conjugated Annexin V labeling (Pharmingen, San Diego CA, USA). Cells were trypsinized, washed with PBS and resuspended in 0.1 M HEPES/NaOH, pH 7.4, 1.4 M NaCl, 25 mM CaCl 2 containing Annexin V-FITC. After 15 min incubation at room temperature, cells were analysed by¯ow cytometry.
Western analysis
After radiation treatment, cultures were washed with phosphate buered saline and disrupted with lysing buer (10 mM sodium phosphate pH 7.5, 100 mM NaCl, 1% Triton X-100, 0.5% deoxycholate, 1 mM phenylmethylsulfonyl¯uor-ide, 15 mg/ml aprotinin). Equal amounts of protein lysates (20 mg) were subjected to 12.5% polyacrylamide gel electrophoresis and then transferred to nitrocellulose membranes. After blocking membranes with 1% low fat milk in Tris buered saline containing 0.05% Tween-20, immunodetection was performed using appropriate dilutions of the primary antibodies. MDM2, E2F-1 and actin antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-p19
ARF was from AbCam (Cambridge, UK) After incubation with the appropiate secondary antibody, membranes were revealed with western blotting luminol reagent (Santa Cruz Biotechnology). Quantitation of the signals was performed by densitometric analysis and represented as arbitrary optical density units.
Electrophoretic mobility shift assays
Nuclear extracts were prepared as described (Andrews and Faller, 1991) and incubated with the oligonucleotide 5'-AGGCTTGGCGGGAAAAAGAACG-3', which contains a consensus binding site for the E2F-1 transcription factor (Oswal et al., 1994) . Conditions for in vitro binding were 40 mM HEPES pH 7.9, 200 mM KCl, 0.5 mM DTT, 0.2 mM EDTA, 5% Ficoll and 3 mg/ml poly (dI-dC). After 30 min of incubation at room temperature, DNA-protein complexes were separated from free 32 P-radiolabeled oligonucleotide on a 5% polyacrylamide gel in 0.56TBE buer (45 mM Tris, 45 mM boric acid and 0.5 mM EDTA, pH 8.0). The speci®city of the DNA-protein complexes were con®rmed by competition experiments with either unlabeled E2F-1 oligonucleotide or an unrelated DNA sequence. For this competition experiments, unlabeled oligonucleotides were preincubated 30 min before the addition of the radioactive probe. 
